IPO registrations (S-1, F-1) · Registrants
DarioHealth Corp.
- SEC CIK
- 1533998 · filings on EDGAR ↗
- Name on the registration
- LabStyle Innovations Corp.
- Former names
- LabStyle Innovations Corp. (2011–2016)
- Registration
- Form S-1, first filed 2013-01-16, last 2016-03-03; 7 initial registrations, 6 amendments
- Outcome
- Final prospectus filed 2016-03-07; declared effective 2013-02-14
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 322 W 57TH ST. #33B, New York, NY 10019
- EIN
- 45-2973162
- Ticker
- DRIO (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- DarioHealth Corp. on the corporate pages
Offering terms
- Final price
- $4.50 per share (424B4 filed 2016-03-07)
- Shares sold
- 1,333,333
- Gross proceeds
- $5,999,998 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol DRIO
- Lead underwriters
- H.C. Wainwright; Joseph Gunnar
- Syndicate
- Rodman & Renshaw
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: DARIOHEALTH CORP. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: DARIOHEALTH CORP. Fuzzy (name and state)
- Form 5500 plan sponsor: DARIOHEALTH CORP EXACT (EIN (EXACT))
- Form D issuer: DarioHealth Corp. EXACT (CIK (EXACT))
- SEC filer: DarioHealth Corp. EXACT (CIK (EXACT))
- Person page: Adam K Stern Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Dennis M Mcgrath Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 28
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2013-01-16 | S-1 | S-1 (registration) | LabStyle Innovations Corp. | 0001144204-13-002580 ↗ |
| 2013-02-12 | S-1/A | S-1/A (amendment) | LabStyle Innovations Corp. | 0001144204-13-007689 ↗ |
| 2013-02-14 | EFFECT | EFFECT (declared effective) | LabStyle Innovations Corp. | 9999999995-13-000524 ↗ |
| 2013-07-10 | S-1 | S-1 (registration) | LabStyle Innovations Corp. | 0001144204-13-038949 ↗ |
| 2013-07-24 | EFFECT | EFFECT (declared effective) | LabStyle Innovations Corp. | 9999999995-13-002190 ↗ |
| 2013-11-06 | EFFECT | EFFECT (declared effective) | LabStyle Innovations Corp. | 9999999995-13-003189 ↗ |
| 2014-03-20 | S-1 | S-1 (registration) | LabStyle Innovations Corp. | 0001144204-14-016910 ↗ |
| 2014-05-19 | S-1/A | S-1/A (amendment) | LabStyle Innovations Corp. | 0001144204-14-032169 ↗ |
| 2014-05-29 | S-1/A | S-1/A (amendment) | LabStyle Innovations Corp. | 0001144204-14-034236 ↗ |
| 2014-06-03 | EFFECT | EFFECT (declared effective) | LabStyle Innovations Corp. | 9999999995-14-001655 ↗ |
| 2014-10-15 | S-1 | S-1 (registration) | LabStyle Innovations Corp. | 0001144204-14-061307 ↗ |
| 2014-10-30 | EFFECT | EFFECT (declared effective) | LabStyle Innovations Corp. | 9999999995-14-003192 ↗ |
| 2015-04-08 | S-1 | S-1 (registration) | LabStyle Innovations Corp. | 0001144204-15-021792 ↗ |
| 2015-04-24 | EFFECT | EFFECT (declared effective) | LabStyle Innovations Corp. | 9999999995-15-000998 ↗ |
| 2015-09-21 | S-1 | S-1 (registration) | LabStyle Innovations Corp. | 0001144204-15-055783 ↗ |
| 2015-10-02 | EFFECT | EFFECT (declared effective) | LabStyle Innovations Corp. | 9999999995-15-002655 ↗ |
| 2016-01-15 | S-1 | S-1 (registration) | LabStyle Innovations Corp. | 0001144204-16-075716 ↗ |
| 2016-02-17 | S-1/A | S-1/A (amendment) | LabStyle Innovations Corp. | 0001144204-16-082882 ↗ |
| 2016-02-25 | S-1/A | S-1/A (amendment) | LabStyle Innovations Corp. | 0001144204-16-084266 ↗ |
| 2016-03-03 | S-1/A | S-1/A (amendment) | LabStyle Innovations Corp. | 0001144204-16-085634 ↗ |
| 2016-03-03 | EFFECT | EFFECT (declared effective) | LabStyle Innovations Corp. | 9999999995-16-003886 ↗ |
| 2016-03-07 | 424B4 | 424B4 (final prospectus) | LabStyle Innovations Corp. | 0001144204-16-086331 ↗ |
| 2016-05-27 | EFFECT | EFFECT (declared effective) | LabStyle Innovations Corp. | 9999999995-16-004786 ↗ |
| 2016-08-03 | EFFECT | EFFECT (declared effective) | DarioHealth Corp. | 9999999995-16-005337 ↗ |
| 2016-12-15 | EFFECT | EFFECT (declared effective) | DarioHealth Corp. | 9999999995-16-006469 ↗ |
| 2017-03-31 | EFFECT | EFFECT (declared effective) | DarioHealth Corp. | 9999999995-17-000716 ↗ |
| 2017-07-21 | EFFECT | EFFECT (declared effective) | DarioHealth Corp. | 9999999995-17-001881 ↗ |
| 2017-10-30 | EFFECT | EFFECT (declared effective) | DarioHealth Corp. | 9999999995-17-002817 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2016-03-03 | S-1/A | registration statement | 1,111,111 | - | OTCQB DRIO | 3 | primary document; shares headline, cover names 3 | document ↗ | ||
| 2016-03-07 | 424B4 | final prospectus | $4.50 | 1,333,333 | $5,999,998 | Nasdaq DRIO | 3 | primary document; price sentence, shares headline, proceeds computed, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Melumad Nahum D | Director | 1 | 2013 | ||
| STERN ADAM K | Director | 29 | 2013–2026 | person page Fuzzy | |
| Weintraub David | Director,TenPercentOwner | 1 | 2013 | ||
| Ben-Zeev Shilo | Director,Officer | President and COO | 1 | 2013 | |
| Fuerst Oren | Director,Officer,TenPercentOwner | Chief Executive Officer | 1 | 2013 | |
| Hershkowitz Mordechi | Officer | Chief Financial Officer | 1 | 2013 | |
| Hoenlein Malcolm | Director | 11 | 2013–2018 | ||
| Ben-David Zvi | Officer | Chief Financial Officer | 32 | 2016–2024 | |
| Karah Hila | Director | 28 | 2016–2026 | ||
| MCGRATH DENNIS M | Director | 28 | 2016–2026 | person page Fuzzy | |
| Raphael Erez | Director,Officer; Director,Officer,TenPercentOwner | Chief Executive Officer | 47 | 2016–2026 | |
| Raviv Ronen | Officer | Controller | 1 | 2016 | |
| STONE RICHARD B | Director | 27 | 2016–2022 | ||
| Yehudiha Hod Rami | Director | 12 | 2016–2018 | ||
| Farhi Shmuel | TenPercentOwner | 3 | 2016 | ||
| Farhi Yalon | Director | 18 | 2016–2020 | ||
| OurCrowd Digital Health L.P. | TenPercentOwner | 1 | 2017 | ||
| Bahagon Yossi | Director,TenPercentOwner; Other | 7 | 2017–2018 | ||
| Kamer Allen | Director; Director,TenPercentOwner | 20 | 2017–2020 | ||
| Bacher Dror | Officer | Chief Operating Officer | 27 | 2017–2022 | |
| Farhi Shehnee | TenPercentOwner | 1 | 2018 | ||
| Zanco Ori | Director | 4 | 2018 | ||
| Shaked Yoav | Director | 22 | 2018–2026 | ||
| Jarry Olivier Roger | Officer | See Remarks | 7 | 2018–2020 | |
| Moller Glen | Director | 6 | 2018–2020 | ||
| ANDERSON RICHARD ALAN | Officer | President; President, GM of North America | 12 | 2020–2024 | |
| Shemmer Yadin | Director | 2 | 2020 | ||
| Matheis Dennis | Director | 10 | 2020–2026 | ||
| Cohen Oded | Officer | GM MSK | 3 | 2021 | |
| KAPLAN JON H. | Director | 4 | 2023–2025 | ||
| Ben-Kiki Tomer | Officer | Chief Operating Officer | 2 | 2024 | |
| Nelson Steven Charles | Officer | Chief Commercial Officer; President and CCO | 9 | 2024–2025 | |
| Leisure Lawrence B. | Director | 2 | 2025 | ||
| Franco-Yehuda Chen | Officer | Chief Financial Officer | 4 | 2025–2026 | |
| PALUMBO JOHN R | Director | 2 | 2026 | ||
| Sherman Lara Ann | Officer | Chief Operating Officer | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-10-07 | DarioHealth Corp. | Other Technology | $17,500,000 | $17,500,000 | 10 | 1 |
| 2025-01-17 | DarioHealth Corp. | Other Technology | $18,805,000 | $18,805,000 | 29 | 1 |
| 2025-01-17 | DarioHealth Corp. | Other Technology | $6,800,000 | $6,800,000 | 18 | 1 |
| 2024-02-29 | DarioHealth Corp. | Other Technology | $22,422,000 | $22,422,000 | 119 | 1 |
| 2023-05-16 | DarioHealth Corp. | Other Technology | $15,400,000 | $15,400,000 | 18 | 1 |
| 2021-06-17 | DarioHealth Corp. | Biotechnology | $24,000,000 | $24,000,000 | 74 | 1 |
| 2021-02-17 | DarioHealth Corp. | Biotechnology | $31,000,000 | $31,000,000 | 30 | 1 |
| 2021-02-03 | DarioHealth Corp. | Biotechnology | $70,000,000 | $70,000,000 | 34 | 1 |
| 2020-08-04 | DarioHealth Corp. | Biotechnology | $30,000,000 | $28,590,801 | 27 | 1 |
| 2019-12-11 | DarioHealth Corp. | Biotechnology | $25,000,000 | $21,375,000 | 167 | 2 |
| 2018-12-20 | DarioHealth Corp. | Biotechnology | $3,000,000 | $3,000,000 | 5 | 1 |
| 2018-03-14 | DarioHealth Corp. | Biotechnology | $6,622,565 | $6,622,565 | 29 | 1 |
| 2017-01-23 | DarioHealth Corp. | Biotechnology | $5,100,000 | $5,100,000 | 20 | 1 |
| 2015-12-02 | LabStyle Innovations Corp. | Biotechnology | $399,999 | $399,999 | 3 | 1 |
| 2015-08-07 | LabStyle Innovations Corp. | Biotechnology | $2,255,391 | $789,550 | 22 | 1 |
| 2015-06-01 | LabStyle Innovations Corp. | Biotechnology | $461,673 | $461,673 | 19 | 1 |
| 2015-03-09 | LabStyle Innovations Corp. | Biotechnology | $3,846,000 | $1,631,560 | 20 | 1 |
| 2014-10-03 | LabStyle Innovations Corp. | Biotechnology | $4,235,000 | $4,235,000 | 15 | 1 |
| 2014-03-05 | LabStyle Innovations Corp. | Biotechnology | $4,186,681 | $4,186,681 | 19 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | DARIOHEALTH CORP. | CA | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | DARIOHEALTH CORP. | NY | State business registries | name and state |
| Form D issuer | DarioHealth Corp. | NY | Form D private offerings | CIK (EXACT) |
| SEC filer | DarioHealth Corp. | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | DARIOHEALTH CORP | EIN (EXACT) | ||
| Person page | Adam K Stern | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Dennis M Mcgrath | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, NY first:
- SWISSRAY INTERNATIONAL INC NY
- BIOPHAN TECHNOLOGIES INC NY
- ANGIODYNAMICS INC NY
- iNeedMD Holdings, Inc. NY
- Nemaura Medical Inc. NY
- PAVmed Inc. NY
- Beyond Air, Inc. NY
- OMNIA WELLNESS INC. NY
- INTELLIGENT BIO SOLUTIONS INC. NY
- Lucid Diagnostics Inc. NY
In other datasets, the same topic (Technology) in NY:
- Lobbying client: 1ST ROCHDALE COOPERATIVE GROUP LTD (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology